Suppr超能文献

人智医学制剂的体外抗菌作用

Antibacterial in vitro effects of preparations from Anthroposophical Medicine.

作者信息

Roser Eva, Gründemann Carsten, Engels Inge, Huber Roman

机构信息

Center for Complementary Medicine, Freiburg, Germany.

Hygiene and Molecular Laboratory, Environmental Health Sciences and Hospital Infection Control, University Medical Center Freiburg, Breisacher Str. 115B, 79106, Freiburg, Germany.

出版信息

BMC Complement Altern Med. 2016 Sep 22;16(1):372. doi: 10.1186/s12906-016-1350-3.

Abstract

BACKGROUND

Medications from Anthroposophical Medicine (AM) are clinically used for the treatment of infections within a whole medical system but have not yet been evaluated regarding antibacterial effects. The aims of this study was to investigate antibacterial activity of AM medications in cell culture.

METHODS

Screening of AM drug registers for preparations used to treat any kind of infection and being available in dilutions ≤ D2 and without alcoholic content. Selected medications were screened for antimicrobial activity against Bacillus subtilis, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa using the agar diffusion method. For antimicrobial active preparations growth kinetics (drop plate method) and minimal inhibitory concentrations (MIC, macrodilution method) were determined.

RESULTS

Thirty-three preparations matched the selection criteria and were chosen for own experiments. One of them (Berberis Decoctum D2) exhibited bactericidal activities against Bacillus subtilis and Staphylococcus aureus, including methicillin resistant strains. The MIC could be determined as 5 mg/ml. The effects could be related to the content of berberine in the extract. No activity towards gram-negative bacteria was found. The other tested extracts had no antibacterial effects.

CONCLUSION

Berberis Decoctum D2 which is used in AM to treat infections exhibits bactericidal effects on Staphylococcus aureus, including methicillin resistant strains.

摘要

背景

人智医学(AM)的药物在整个医疗体系中临床上用于治疗感染,但尚未对其抗菌效果进行评估。本研究的目的是在细胞培养中研究AM药物的抗菌活性。

方法

筛查AM药物登记册,寻找用于治疗任何类型感染且稀释度≤D2且无酒精成分的制剂。使用琼脂扩散法筛选所选药物对枯草芽孢杆菌、大肠杆菌、金黄色葡萄球菌和铜绿假单胞菌的抗菌活性。对于具有抗菌活性的制剂,测定生长动力学(滴板法)和最低抑菌浓度(MIC,大稀释法)。

结果

33种制剂符合选择标准并被选用于自身实验。其中一种(小檗煎剂D2)对枯草芽孢杆菌和金黄色葡萄球菌具有杀菌活性,包括耐甲氧西林菌株。MIC可确定为5mg/ml。其效果可能与提取物中的黄连素含量有关。未发现对革兰氏阴性菌有活性。其他测试提取物无抗菌作用。

结论

AM中用于治疗感染的小檗煎剂D2对金黄色葡萄球菌具有杀菌作用,包括耐甲氧西林菌株。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c550/5034436/cfb8fb74a392/12906_2016_1350_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验